Topics

In our latest feature, @AstraZeneca's Patrick Connor discusses his company’s role in the newly announced #LungAmbitionAlliance and its ambitious strategy to double five-year survival in #LungCancer by 2025 http://bit.ly/2MjxIPk  #pharma

14:00 EDT 7 Oct 2019 | Pharmafile

In our latest feature, 's Patrick Connor discusses his company’s role in the newly announced and its ambitious strategy to double five-year survival in by 2025 http://bit.ly/2MjxIPk 

Original Article: In our latest feature, @AstraZeneca's Patrick Connor discusses his company’s role in the newly announced #LungAmbitionAlliance and its ambitious strategy to double five-year survival in #LungCancer by 2025 http://bit.ly/2MjxIPk  #pharma

NEXT ARTICLE

More From BioPortfolio on "In our latest feature, @AstraZeneca's Patrick Connor discusses his company’s role in the newly announced #LungAmbitionAlliance and its ambitious strategy to double five-year survival in #LungCancer by 2025 http://bit.ly/2MjxIPk  #pharma"

Quick Search